Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer

Heymach John V., Johnson Bruce E., Prager Diane, Csada Edit, Roubec Jaromír, Pešek Miloš, Špásová Irena, Belani Chandra P., Bodrogi István, Gadgeel Shirish, Kennedy Sarah J., Hou Jennie, Herbst Roy S.
2007